Skip to content

MammoStar™ STAR1101Recalls & reported problems

Carbon Medical Technologies, Inc. · Biopsy Site Identifier · Class 2 · Implant

All models of MammoStar (11)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00858015005394), received between Jan 25, 2023 and Jan 25, 2023 — classified as 1 malfunction.

The most frequently reported specific device problem is “Migration or Expulsion of Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Migration or Expulsion of Device1

Patient problems

  • Insufficient Information1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 25, 2023Migration or Expulsion of Device

    MAMMOSTAR BIOPSY MARKERS ARE MIGRATING WITHIN THE BREAST TISSUE OF PATIENTS FOLLOWING THEIR PLACEMENT WITH A BREAST TISSUE BIOPSY. AS A RESULT, PATIENTS PRESENT IN FOLLOW-UP WITH THEIR ORIGINAL BIOPSY SITE MARKERS IMPROPERLY PLACED. MANUFACTURER SENT A NEW MODEL.

    Patient problems: Insufficient Information

    MAUDE report 16239991 ↗

Other Marker, Radiographic, Implantable devices

All Marker, Radiographic, Implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page